GHRH and cancer: These findings have paved the way for the development of synthetic GHRH agonists and antagonists, which hold great promise for therapeutic applications in conditions ranging from GH deficiency and metabolic disorders to cancer, cardiovascular and neurodegenerative diseases [5].